Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Wyatt KM, Dimmock PW, O'Brien PM.

Cochrane Database Syst Rev. 2002;(4):CD001396. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001396.

PMID:
12519554
[PubMed - indexed for MEDLINE]
2.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Brown J, O' Brien PM, Marjoribanks J, Wyatt K.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001396. doi: 10.1002/14651858.CD001396.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD001396.

PMID:
19370564
[PubMed - indexed for MEDLINE]
3.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Marjoribanks J, Brown J, O'Brien PM, Wyatt K.

Cochrane Database Syst Rev. 2013 Jun 7;6:CD001396. doi: 10.1002/14651858.CD001396.pub3. Review.

PMID:
23744611
[PubMed - indexed for MEDLINE]
4.

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review.

Dimmock PW, Wyatt KM, Jones PW, O'Brien PM.

Lancet. 2000 Sep 30;356(9236):1131-6.

PMID:
11030291
[PubMed - indexed for MEDLINE]
5.

Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough.

Halbreich U.

CNS Spectr. 2008 Jul;13(7):566-72. Review.

PMID:
18622361
[PubMed - indexed for MEDLINE]
6.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD006586. doi: 10.1002/14651858.CD006586.pub4. Review.

PMID:
22336820
[PubMed - indexed for MEDLINE]
7.

Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J.

Obstet Gynecol. 2008 May;111(5):1175-82. doi: 10.1097/AOG.0b013e31816fd73b.

PMID:
18448752
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.

Jarvis CI, Lynch AM, Morin AK.

Ann Pharmacother. 2008 Jul;42(7):967-78. doi: 10.1345/aph.1K673. Epub 2008 Jun 17.

PMID:
18559957
[PubMed - indexed for MEDLINE]
9.

Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Steiner M.

J Psychiatry Neurosci. 2000 Nov;25(5):459-68. Review.

PMID:
11109297
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Progesterone for premenstrual syndrome.

Ford O, Lethaby A, Roberts H, Mol BW.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD003415. doi: 10.1002/14651858.CD003415.pub4. Review.

PMID:
22419287
[PubMed - indexed for MEDLINE]
11.

Progesterone for premenstrual syndrome.

Ford O, Lethaby A, Roberts H, Mol BW.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003415. doi: 10.1002/14651858.CD003415.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD003415.

PMID:
19370587
[PubMed - indexed for MEDLINE]
12.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
[PubMed - indexed for MEDLINE]
13.

Progesterone for Premenstrual Syndrome.

Ford O, Lethaby A, Mol B, Roberts H.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003415. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD003415.

PMID:
17054168
[PubMed - indexed for MEDLINE]
14.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006586. doi: 10.1002/14651858.CD006586.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD006586.

PMID:
19370644
[PubMed - indexed for MEDLINE]
15.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein A, Helmerhorst FM.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006586. doi: 10.1002/14651858.CD006586.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD006586.

PMID:
18254106
[PubMed - indexed for MEDLINE]
16.

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.

Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. Review.

PMID:
16417420
[PubMed - indexed for MEDLINE]
17.

Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.

Frackiewicz EJ, Shiovitz TM.

J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):437-47. Review.

PMID:
11372908
[PubMed - indexed for MEDLINE]
18.

Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.

Steiner M, Pearlstein T.

J Clin Psychiatry. 2000;61 Suppl 12:17-21. Review.

PMID:
11041380
[PubMed - indexed for MEDLINE]
19.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
[PubMed - indexed for MEDLINE]
20.

The role of fluoxetine in the treatment of premenstrual dysphoric disorder.

Romano S, Judge R, Dillon J, Shuler C, Sundell K.

Clin Ther. 1999 Apr;21(4):615-33; discussion 613. Review.

PMID:
10363729
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk